The National Pharmaceutical Pricing Authority (“NPPA”), after reviewing the Wholesale Price Index (WPI) at 0.00551% for the year 2024, has revised the ceiling price of malaria drug chloroquine phosphate 150 mg, following a direction from the Department of Pharmaceuticals (DoP).
| Medicines | Dosage Form & Strength | Unit | Ceiling Price under NLEM 2022 (Rs.) | Revised Ceiling price based on Review Order & considering WPI @0.00551% (Rs.) | Review Order Number and Date | Existing SO number and date |
| Chloroquine | Tablet 150 mg | 1 tablet | 1.17 | 1.33 | 31015/30/2023-Pricing dated 28.05.2024 | 1547(E) dated
26.03.2024 (Sl. No. 134) |
Manufacturers of the specified scheduled formulations are directed to adjust their prices to not exceed the ceiling price set by the government plus any applicable Goods and Services Tax (GST). Those with prices below the ceiling should maintain their current pricing. GST can only be added if actually paid.
A copy of the Notification is attached herewith for ease of reference.
Source: National Pharmaceutical Pricing Authority
